Research and Markets has announced the addition of the "Europe Scleroderma Market and Competitive Landscape Highlights - 2016" report to their offering.
Europe Scleroderma Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Scleroderma pipeline products, Scleroderma epidemiology, Scleroderma market valuations and forecast, Scleroderma products sales and competitive landscape.
The research focuses on key countries such as Germany, France, Italy, Spain, and UK. This report is classified into nine sections - Scleroderma overview including etiology, pathophysiology, and diagnosis, Scleroderma treatment options, Scleroderma pipeline products, Scleroderma market analysis in Europe and by each country.
The market analysis comprises of Scleroderma epidemiology, key products marketed for Scleroderma, market valuations and forecast, products sales and market shares.
Research Scope:
- Pipeline: Find out the products in clinical trials for the treatment of Scleroderma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Epidemiology: Find out the number of patients diagnosed (prevalence) with Scleroderma in Germany, France, Italy, Spain, and UK
- Products: Identify key products marketed and prescribed for Scleroderma in Germany, France, Italy, Spain, and UK, including trade name, molecule name, and company
- Product Sales: Find out the sales revenues of Scleroderma products, both branded and generics, in Germany, France, Italy, Spain, and UK
- Market Valuations: Find out the market size for Scleroderma products in 2015 for the markets: Germany, France, Italy, Spain, UK, and Germany. Find out how the market advanced from 2010 and forecast to 2020
- Products Market Share: Find out the market shares for key Scleroderma products in Germany, France, Italy, Spain, and UK
Key Topics Covered:
1 Disease Overview
2 Scleroderma Treatments
3 Scleroderma Pipeline
4 Europe Scleroderma Market Insights
5 Germany Scleroderma Market Insights
6 France Scleroderma Market Insights
7 Italy Scleroderma Market Insights
8 Spain Scleroderma Market Insights
9 UK Scleroderma Market Insights
For more information visit http://www.researchandmarkets.com/research/g2zpq6/europe
View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005524/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Dermatological
Drugs , Musculoskeletal
Disorders Drugs
